October 19, 2017 2:06 PM ET

Biotechnology

Company Overview of PaxVax Corporation

Key Executives for PaxVax Corporation

NameBoard RelationshipsTitleAge
Nima Farzan 7 RelationshipsChief Executive Officer, President and Director--
Philip K. Moody No RelationshipsChief Financial Officer and Executive Vice President65
Marc Gurwith M.D., J.D.No RelationshipsChief Medical Officer78
Mark Meltz No RelationshipsChief Legal Officer and Executive Vice President--
Jonathan F. Smith Ph.D. No RelationshipsChief Scientific Officer and Executive Vice President--

PaxVax Corporation Board Members*

NameBoard RelationshipsPrimary CompanyAge
Dean Jonathan Mitchell 33 RelationshipsCovis Pharma, S.à.r.l.61
Nima Farzan 7 RelationshipsPaxVax Corporation--
James Edward Connolly 11 RelationshipsTivorsan Pharmaceuticals, Inc--
James E. Geisler 40 RelationshipsKeane Group, Inc.50
Jon Anderson CPA 24 RelationshipsIgnition Capital--
View All Board Members

PaxVax Corporation Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
There is no committee data available.
*Data is at least as current as the most recent Definitive Proxy.
\
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary
390.5K
Bonus
244.7K
Total Short Term Compensation
487.0K
Total Value of Options
17.9M
Compensation as of Fiscal Year
PaxVax Corporation CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

PolyNovo Announces Change of Company Secretary
October 19, 2017 4:31 AM ET
Marina Biotech, Inc. Appoints Peter D. Weinstein as Chief Legal Officer, Effective October 12, 2017
October 18, 2017 9:01 PM ET
Spectral Medical Inc Announces Retirement of Tony Businskas as Executive Vice President and CFO
October 18, 2017 12:00 PM ET
Tissue Regenix Group plc Announces Executive Changes
October 18, 2017 6:00 AM ET
Monash IVF Group Ltd. Announces the Appointment of David Morris as Chief Executive Officer and Managing Director, Effective 13 November 2017
October 17, 2017 10:12 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact PaxVax Corporation, please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.